Sudden Cardiac Death in Acute Coronary Syndromes
Nikolaos Dagres1, Gerhard Hindricks1
1Department of Electrophysiology, University Leipzig - Heart Center, Strümpellstr. 39, Leipzig 04289, Germany.
Insights
Sudden cardiac death from ventricular arrhythmias in acute coronary syndromes is reduced by contemporary management. Treatment includes electrical cardioversion, revascularization, and medications like beta-blockers and amiodarone.
Area of Science:
- Cardiology
- Electrophysiology
- Critical Care Medicine
Background:
- Sudden cardiac death (SCD) in acute coronary syndromes (ACS) is primarily caused by ventricular arrhythmias.
- Despite advances in management, ventricular arrhythmias remain a significant threat to patients with ACS.
Purpose of the Study:
- To summarize the current understanding and management strategies for ventricular arrhythmias in the context of acute coronary syndromes.
- To highlight the role of various therapeutic interventions in preventing and treating these life-threatening events.
Main Methods:
- Review of current literature on the pathophysiology and management of ventricular arrhythmias in ACS.
- Analysis of established and emerging treatment modalities, including electrical cardioversion, revascularization, pharmacotherapy, and catheter ablation.
Main Results:
- Immediate electrical cardioversion and prompt coronary revascularization are crucial for terminating and managing acute episodes.
- Prophylactic beta-blockers offer protective benefits.
- For recurrent arrhythmias, treatment involves beta-blockers and amiodarone, with lidocaine as an alternative for nonresponsive cases.
- Catheter ablation is effective for specific recurrent ventricular tachyarrhythmias.
Conclusions:
- Ventricular arrhythmias in ACS require a multi-faceted treatment approach.
- Pharmacologic and interventional strategies, tailored to individual patient needs, are essential for reducing SCD risk.
- Ongoing research and clinical practice aim to further improve outcomes for patients at risk.
Abstract:
Sudden cardiac death in acute coronary syndromes mostly results from complex ventricular arrhythmias. Although the incidence has fallen with contemporary management, they still pose a threat for many patients. Treatment consists of immediate termination by electrical cardioversion and prompt coronary revascularization for relief of ischemia. Beta-blockers administered prophylactically have a protective effect. For recurrent episodes, pharmacologic treatment consists of beta-blockers and amiodarone, or, in nonresponsive patients, lidocaine. Other antiarrhythmic drugs play only a marginal role. Catheter ablation performed in qualified centers can be effective in recurrent episodes of ventricular tachycardia or ventricular fibrillation triggered by premature ventricular contractions.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
06:39Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Introduction Cardiac Emergencies
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
